tiprankstipranks
Advertisement
Advertisement
Invivyd: Multi‑Virus Antibody Platform Progress and Pivotal COVID-19 Trial Support Buy Rating and $10 Target
PremiumRatingsInvivyd: Multi‑Virus Antibody Platform Progress and Pivotal COVID-19 Trial Support Buy Rating and $10 Target
1M ago
Midday Fly By: Ares to acquire Whitestone REIT, Disney to make ‘sizable’ layoffs
Premium
The Fly
Midday Fly By: Ares to acquire Whitestone REIT, Disney to make ‘sizable’ layoffs
1M ago
Invivyd provides update on Phase 3 DECLARATION study of VYD2311
Premium
The Fly
Invivyd provides update on Phase 3 DECLARATION study of VYD2311
1M ago
Invivyd: Late‑Stage COVID-19 Antibody Progress and Solid Fundamentals Support Buy Rating
PremiumRatingsInvivyd: Late‑Stage COVID-19 Antibody Progress and Solid Fundamentals Support Buy Rating
2M ago
Invivyd Advances VYD2311 With Key Phase 3 Alignments
Premium
Company Announcements
Invivyd Advances VYD2311 With Key Phase 3 Alignments
2M ago
Invivyd reports cash, cash equivalents of $226.7M as of December 31
Premium
The Fly
Invivyd reports cash, cash equivalents of $226.7M as of December 31
2M ago
Invivyd management to meet virtually with BTIG
PremiumThe FlyInvivyd management to meet virtually with BTIG
3M ago
XBI vs. IBB: Which Biotech ETF do Analysts Prefer in 2026?
Premium
Market News
XBI vs. IBB: Which Biotech ETF do Analysts Prefer in 2026?
3M ago
Invivyd aligns with FDA on LIBERTY Phase 3 trial of VYD2311
Premium
The Fly
Invivyd aligns with FDA on LIBERTY Phase 3 trial of VYD2311
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100